Mayer Arie - Insider Non-Derivative Transactions at ORAMED PHARMACEUTICALS INC. (ORMP) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 4, 2024, Mayer Arie's relationship to ORAMED PHARMACEUTICALS INC. (ORMP) is Director, and currently has 96,134 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ORMP insiders.
Data Source: SEC.
Mayer Arie - Insider Non-Derivative Transactions of ORMP Common Stock
Mayer Arie - Insider Non-Derivative Transactions at ORMP
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 5, 2024 | Acquisition -- (Common Stock) | 30000 | 0 | 86809 |
| Jan 5, 2024 | Acquisition -- (Common Stock) | 9325 | 0 | 96134 |
| Apr 18, 2023 | Acquisition -- (Common Stock) | 30000 | 0 | 56809 |
| Apr 5, 2023 | P -- (Common Stock) | 3800 | 2.21 | 26809 |
| Apr 4, 2023 | P -- (Common Stock) | 5009 | 2.22 | 23009 |